Delivery Order SPE2DB20D3103-SPE2DB26FL3S6
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $15,484.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 6, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order calls for pharmaceutical products...
- The Defense Logistics Agency Medical Supply Chain awarded a $22,535.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 11, 2025, with an ultimate completion date of October 14, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The delivery order will be performed at the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $10,473.58 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition...
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,745.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 15, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the contractor's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $58,103.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of the same day. This competitive, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,220.24 to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order will be fulfilled from the vendor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,479 to AmerisourceBergen Drug Corp on September 21, 2025, for pharmaceutical products and medical supplies. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999.99M ceiling and runs through December 2026. The delivery order carries no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $4,027.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, with a completion date of September 5, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The contract is performed at the company's corporate office location...
- The Defense Logistics Agency awarded a $13,421.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $4,583.67 to AmerisourceBergen Drug Corp on October 27, 2025, with an ultimate completion date of October 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contractor, headquartered in...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL3S6Delivery Order
The Defense Logistics Agency awarded a $3,497.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Miostat Vial 1.5ML, a pharmaceutical product used primarily in ophthalmic procedures. This non-set-aside delivery order is scheduled for completion by October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, holds a $999.999 billion Indefinite Delivery/Indefinite Quantity contract with the Defense Logistics Agency through December 2026 that enables the company to supply a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare operations globally. The company's extensive federal procurement history with DLA demonstrates its capability to deliver diverse medical commodities, including specialty medications, vaccines, and medical devices, to support Defense Health Agency requirements and other federal healthcare systems. This delivery order for Miostat is issued under that overarching pharmaceutical supply agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 10/23/25 |